Clinical Research Directory
Browse clinical research sites, groups, and studies.
Assessing an EEG Biomarker of Response to TMS for Major Depression
Sponsor: VA Office of Research and Development
Summary
Veterans with treatment resistant depression (TRD) have the opportunity to receive transcranial magnetic stimulation (TMS) treatment via the VA's National TMS Clinical Pilot Program. While some see improvement with their depression, others do not. Therefore, it may be beneficial to be able to predict with biomarkers what participants may see improvement with their treatment. Electroencephalography (EEG) is a means to identify such biomarkers. Four hundred Veterans with TRD will be enrolled in this trial to determine whether neuroimaging biomarkers of repetitive transcranial magnetic stimulation (TMS) can be prospectively replicated in a large ecologically valid sample. Participants will have a total of EEG scans at baseline, every 5th treatment session, and at the end of treatment for a total of 7 EEG scans.
Official title: Assessing an Electroencephalography (EEG) Biomarker of Response to Transcranial Magnetic Stimulation for Major Depression
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
266
Start Date
2021-08-19
Completion Date
2026-09-30
Last Updated
2025-10-22
Healthy Volunteers
No
Conditions
Interventions
Transcranial Magnetic Stimulation
Transcranial Magnetic Stimulation is delivered as part of routine care and is not managed by this observational study.
Locations (1)
White River Junction VA Medical Center, White River Junction, VT
White River Junction, Vermont, United States